Antibody-drug conjugates (ADCs) represent a significant leap forward in targeted cancer therapy, a sophisticated class of drugs that marries the…
Read More
Bioengineered Bone Marrow Platform Replicates Human Immune System and Offers New Frontiers for Drug Development and Space Medicine
The human bone marrow serves as a silent but tireless factory, situated within the skeletal cavities, where it orchestrates the…
Read More
TrumpRx.gov: A Federal Portal’s Ambitions and the Intensifying Scrutiny of Direct-to-Consumer Drug Sales
As of early February, TrumpRx.gov presents a starkly minimalist facade: a stylized Oval Office portrait of the president accompanied by…
Read More
The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis
A paradigm shift in the understanding of GLP-1 receptor agonists, widely recognized as transformative agents in the battle against obesity…
Read More
The Crucial Role of Payload Linker Innovation in the Rapidly Expanding Antibody-Drug Conjugate Market
Combining the targeted precision of monoclonal antibodies with the potent destructive power of cytotoxic payloads, Antibody-Drug Conjugates (ADCs) represent a…
Read More
Unraveling the Malaria Parasite’s Molecular Choreography: A Specialized Protein Emerges as a Potent Drug Target
Researchers from a consortium of leading international institutions have unveiled groundbreaking insights into the intricate mechanisms governing the growth and…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
A groundbreaking international collaboration, fortified by a prestigious pan-European EUREKA grant, has been officially launched to pioneer the development of…
Read More
Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay
A groundbreaking development from a collaborative team at ETH Zurich and Karolinska Institutet promises to revolutionize early-stage drug discovery by…
Read More
Can live cell dynamics fix drug discovery’s efficacy problem?
The pharmaceutical industry faces an escalating crisis marked by soaring costs, protracted timelines, and persistently low success rates in bringing…
Read More
